Skip to main content
    K

    Kamada (KMDA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $8.11
    +0.02 (+0.25%)

    Market Cap: $467.05M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Kamada (KMDA) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Kamada (KMDA) trades at 18.9x trailing earnings and 2.4x sales. Its P/E of 18.9x is below its 5-year median of 23.3x. Its forward P/E is 16.1x. The median P/E across 4 similar companies is 7.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 17.4% higher over the next year. Its free cash flow yield is 7.6%.

    MultipleValue
    P/E (trailing)18.9x
    Forward P/E16.1x
    Price to sales2.4x
    Price to book1.7x
    Price to FCF13.1x
    PEG0.6
    FCF yield7.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 14.3% above 2.1x and its P/B is 6.3% above 1.6x.

    MultipleCurrent5-year median10-year median
    P/E18.9x23.3xN/A
    P/S2.4x2.1x2.1x
    P/B1.7x1.4x1.6x
    Medians of month-end values through Oct 2026: 48 to 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 8 of the 10 year ends shown that have a P/E, its P/E ranged from 8.9x in 2018 to 133.7x in 2022.

    Year endPriceP/EP/SP/B
    2025$7.0620.2x2.3x1.6x
    2024$6.0923.4x2.1x1.3x
    2023$6.1240.8x2.1x1.4x
    2022$4.01133.7x1.4x1.0x
    2021$6.58N/A2.8x1.7x
    2020$6.4816.6x2.0x1.5x
    2019$6.8312.9x2.2x2.1x
    2018$5.008.9x1.8x1.8x
    2017$4.7527.9x1.8x2.1x
    2016$5.45N/A2.6x3.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About KMDA

    What is KMDA's forward P/E ratio?

    Kamada has a forward P/E ratio of 16.1x.

    Is KMDA stock overvalued?

    GNG's valuation label for KMDA is Undervalued. Its P/E of 18.9x compares with a median of 7.8x across 4 similar companies.

    What is KMDA's price to sales ratio?

    Kamada has a price to sales ratio of 2.4x.

    What is Kamada's average P/E ratio over 5 years?

    Kamada's median P/E over the last 5 years is 23.3x, from 48 month-end values through Oct 2026.

    What is KMDA's PEG ratio?

    Kamada has a PEG ratio of 0.6.